Trial Profile
A randomized, double-blind, parallel-group, placebo-controlled study evaluating the efficacy and safety of vardenafil administered for 12 weeks in a flexible-dose regimen compared to placebo in male erectile dysfunction subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Bayer; GSK
- 06 May 2008 New trial record.